Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

Aller à Demande

1. KR1020060006949 - ANTISOLVENT SOLIDIFICATION PROCESS

Office République de Corée
Numéro de la demande 1020057020462
Date de la demande 28.10.2005
Numéro de publication 1020060006949
Date de publication 20.01.2006
Type de publication A
CIB
B01D 9/00
BTECHNIQUES INDUSTRIELLES; TRANSPORTS
01PROCÉDÉS OU APPAREILS PHYSIQUES OU CHIMIQUES EN GÉNÉRAL
DSÉPARATION
9Cristallisation
CPC
B01D 9/0063
BPERFORMING OPERATIONS; TRANSPORTING
01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
DSEPARATION
9Crystallisation
0063Control or regulation
A61K 9/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
A61K 9/1688
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
16Agglomerates; Granulates; Microbeadlets ; ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
1682Processes
1688resulting in pure drug agglomerate optionally containing up to 5% of excipient
A61K 31/57
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
57substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
B01D 9/005
BPERFORMING OPERATIONS; TRANSPORTING
01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
DSEPARATION
9Crystallisation
005Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
C01D 3/24
CCHEMISTRY; METALLURGY
01INORGANIC CHEMISTRY
DCOMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
3Halides of sodium, potassium or alkali metals in general
22Preparation in the form of granules, pieces, or other shaped products
24Influencing the crystallisation process
Déposants AKZO NOBEL N.V.
아크조 노벨 엔.브이.
Inventeurs BAKKER WRIDZER JAN WILLEM
바커 브리드저 쟌 빌렘
GEERTMAN ROBERT MICHAEL
게어트만 로베르트 미카엘
REEDIJK MARIANNE FREDERIKA
리디즈크 마리안네 프레데리카
BALTUSSEN JOZEF JOHANNES MARIA
발투센 죠제프 죠한네스 마리아
BARGEMAN GERRALD
바르게만 게랄드
VAN LARE CORNELIS ELIZABETH JOHANNUS
반 라레 코르넬리스 엘리자베스 죠한누스
Mandataires 김명신
김국현
이영일
박장규
Données relatives à la priorité 60/466,761 29.04.2003 US
Titre
(EN) ANTISOLVENT SOLIDIFICATION PROCESS
(KO) 반용매 고화 방법
Abrégé
(EN)

The present invention relates to a antisolvent solidification process wherein a liquid medium comprising at least one organic or inorganic compound which is to be solidified is forced through a membrane into one or more antisolvents, or wherein one or more antisolvents are forced through a membrane into a liquid medium comprising at least one organic or inorganic compound which is to be solidified, yielding a composition comprising solid particles comprising said organic and/or inorganic compound(s).

© KIPO & WIPO 2007

(KO)
본 발명은 반용매 고화 방법에 관한 것으로서,

Également publié en tant que
IL171613
NO20055607
NZ543772
RU2005136983
US2006182808
ZA200509597
Autres publications associées